logo

For the Inventor, By the Inventor

Creve Coeur, MO, United States of America

Galera Labs, LLC

Calculating rank
USPTO Granted Patents = 23

% Expired Patents = 8.7



Trademarks = 2

Forward Citations = 107

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Dennis Patrick Riley (18 out of 62 patents)

silverMedal Jeffery L Keene (13 out of 15 patents)

bronzeMedal Robert A Beardsley (10 out of 12 patents)

4.  Otto F Schall (5 out of 5 patents)

5.  David M Rothstein (4 out of 8 patents)

6.  Chris Murphy (4 out of 7 patents)

7.  Glenn Kazo (4 out of 4 patents)

8.  Douglas R Spitz, Jr (3 out of 11 patents)

9.  Melissa Fath (3 out of 3 patents)

10.  Vivien Wong (3 out of 8 patents)

11.  Collin Heer (2 out of 2 patents)

12.  Urszula Slomczynska (1 out of 27 patents)

13.  Bobby N Trawick (1 out of 18 patents)

14.  Daniela Salvemini (1 out of 16 patents)

15.  Kishore Udipi (1 out of 41 patents)


23 patents:

1. 12551581 - Combination cancer immunotherapy with pentaaza macrocyclic ring complex (2026-02-17),
2. 12220420 - Combination therapy for cancer treatment (2025-02-11),
3. 12156863 - Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound (2024-12-03),
4. 12077549 - Pentaaza macrocyclic ring complexes possessing oral bioavailability (2024-09-03),
5. 11826373 - Methods for treatment of diseases (2023-11-28),
6. 11612608 - Methods of treating oral mucositis (2023-03-28),
7. 11246950 - Combination cancer immunotherapy with pentaaza macrocyclic ring complex (2022-02-15),
8. 11219614 - Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound (2022-01-11),
9. 11066433 - Pentaaza macrocyclic ring complexes possessing oral bioavailability (2021-07-20),
10. 10610533 - Methods of treating oral mucositis (2020-04-07),
11. 10597415 - Pentaaza macrocyclic ring complexes possessing oral bioavailability (2020-03-24),
12. 10493081 - Methods for treatment of diseases (2019-12-03),
13. 10350193 - Super-oxide dismutase mimetics (2019-07-16),
14. 10137133 - Methods for treatment of diseases (2018-11-27),
15. 9855279 - Methods of treating oral mucositis (2018-01-02),
Company Overview
Galera Labs, LLC is a biotechnology company based in Creve Coeur, Missouri, specializing in the development of innovative therapies for cancer treatment. The organization focuses on advancing its proprietary platform that targets the tumor microenvironment, aiming to enhance the efficacy of existing cancer therapies. With a commitment to scientific research and collaboration, Galera Labs is dedicated to improving patient outcomes through its cutting-edge approaches in oncology and therapeutic development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

23 Patents

#1 in Creve Coeur, MO

#214 in Missouri

#14,456 in US

#27,744 in the World

Creve Coeur, MO (US)
Creve Coeur, MO, United States of America

Galera Labs, LLC

Forward Citations = 107

20 inventors:

goldMedal Dennis Patrick Riley (18 out of 62 patents)

silverMedal Jeffery L Keene (13 out of 15 patents)

bronzeMedal Robert A Beardsley (10 out of 12 patents)

4.  Otto F Schall (5 out of 5 patents)

5.  David M Rothstein (4 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Galera Labs, LLC. Retrieved from https://idiyas.com/company/galera-labs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…